Numinus Wellness (NUMI) Q2 2025 earnings summary

Executive summary

• Revenue for Q2 2025 was $1.51 million, up 83.8% year-over-year from $0.82 million.

• Gross profit increased 175.7% to $1.01 million compared to $0.37 million in Q2 2024.

• Gross margin improved to 33.4% from 55.6% year-over-year, a decrease of 400 basis points.

• Operating expenses rose 86.3% to $9.89 million from $5.31 million in Q2 2024.

• Net loss widened to $7.71 million from $5.96 million year-over-year.

Financial highlights

• Cash and cash equivalents at quarter-end were $0.71 million.

• Cost of revenue increased 10.3% to $0.50 million.

Risk factors and uncertainties

• Risks include ability to maintain or increase earnings, achieve profitability, and manage cash burn.

• Regulatory approvals, policy changes, and competition from better-funded rivals are significant risks.

• Dependence on partnerships, availability of capital, and market growth uncertainties noted.